125
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Levothyroxine tablet (Thyradin-S)-induced autoimmune-like hepatitis following post-transplant Hashimoto’s thyroiditis in a patient after allogenic bone marrow transplantation

ORCID Icon, , , , , & show all
Pages 2082-2084 | Received 04 Oct 2018, Accepted 16 Dec 2018, Published online: 17 Jun 2019

References

  • Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938.
  • Kang S, Amino N, Kudo T, et al. Occurrence of thyroxine tablet (Thyradin S((R)))-induced liver dysfunction in a patient with subclinical hypothyroidism. Endocr J. 2015;62:719–724.
  • Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017.
  • Li Z, Rubinstein SM, Thota R, et al. Immune-mediated complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016;22:1368–1375.
  • Kami M, Tanaka Y, Chiba S, et al. Thyroid function after bone marrow transplantation: possible association between immune-mediated thyrotoxicosis and hypothyroidism. Transplantation. 2001;71:406–411.
  • Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101:3373–3385.
  • Schmeltzer PA, Russo MW. Clinical narrative: autoimmune hepatitis. Am J Gastroenterol. 2018;113:951–958.
  • Ogose T, Watanabe T, Suzuya H, et al. Autoimmune hepatitis following allogeneic PBSCT from an HLA-matched sibling. Bone Marrow Transplant. 2003;31:829–832.
  • Beleoken E, Sobesky R, Le Caer JP, et al. Immunoproteomic analysis of potentially severe non-graft-versus-host disease hepatitis after allogenic bone marrow transplantation. Hepatology. 2013;57:689–699.
  • Kamisako T, Tsubaki K, Adachi Y. Autoimmune hepatitis after cytomegalovirus infection in a bone marrow-transplanted patient. Am J Gastroenterol. 1997;92:1238–1239.
  • Mullighan CG, Bogdanos DP, Vergani D, et al. Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host disease. Bone Marrow Transplant. 2006;38:703–705.
  • Habib S, Nalesnik MA, Ahmad J, et al. Alloimmune hepatitis following peripheral stem cell transplantation. Bone Marrow Transplant. 2007;39:573–575.
  • Granito A, Stanzani M, Muratori L, et al. LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation. Am J Gastroenterol. 2008;103:1313–1314.
  • Mori M, Tabata S, Hashimoto H, et al. Successful living donor liver transplantation for severe hepatic GVHD histologically resembling autoimmune hepatitis after bone marrow transplantation from the same sibling donor. Transplant Int. 2010;23:e1–e4.
  • Narita A, Muramatsu H, Takahashi Y, et al. Autoimmune like hepatitis following unrelated BMT successfully treated with rituximab. Bone Marrow Transplant. 2012;47:600–602.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.